• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Changing the Way We Pay for Health Care: Is Value the New Plastic?改变医疗保健付费方式：价值是新的塑料吗？
J Manag Care Spec Pharm. 2017 Oct;23(10):998-1002. doi: 10.18553/jmcp.2017.23.10.998.
2
Paying for Cures: How Can We Afford It? Managed Care Pharmacy Stakeholder Perceptions of Policy Options to Address Affordability of Prescription Drugs.支付治疗费用：我们如何负担得起？ 探讨解决处方药可负担性问题的政策选择对管理式医疗保健药房利益相关者的影响
J Manag Care Spec Pharm. 2017 Oct;23(10):1084-1090. doi: 10.18553/jmcp.2017.23.10.1084.
3
Performance-Based Risk-Sharing Arrangements: U.S. Payer Experience.基于绩效的风险分担安排：美国支付方的经验。
J Manag Care Spec Pharm. 2017 Oct;23(10):1042-1052. doi: 10.18553/jmcp.2017.23.10.1042.
4
AMCP Partnership Forum: Designing Benefits and Payment Models for Innovative High-Investment Medications.AMCP 合作论坛：为创新性高投入药物设计获益和支付模式。
J Manag Care Spec Pharm. 2019 Feb;25(2):156-162. doi: 10.18553/jmcp.2019.25.2.156.
5
Pharmacy expenditures: the challenges of balancing access, cost, and value.药房支出：平衡可及性、成本和价值的挑战。
Am J Manag Care. 2003 Jun;Suppl Decision Maker News:1-4.
6
AMCP Partnership Forum: FDAMA Section 114-Improving the Exchange of Health Care Economic Data.AMCP 合作论坛：FDAMA 第 114 节——改善医疗保健经济数据的交流。
J Manag Care Spec Pharm. 2016 Jul;22(7):826-31. doi: 10.18553/jmcp.2016.22.7.826.
7
The Effect of Formulary Restrictions on Patient and Payer Outcomes: A Systematic Literature Review.《医保目录限制对患者和支付方结果的影响：系统文献回顾》。
J Manag Care Spec Pharm. 2017 Aug;23(8):893-901. doi: 10.18553/jmcp.2017.23.8.893.
8
Methodology for conducting a comprehensive product review in managed care.在托管式医疗中进行全面产品审查的方法。
J Manag Care Spec Pharm. 2023 Mar;29(3):237-243. doi: 10.18553/jmcp.2023.29.3.237.
9
Assessment of the Level of Satisfaction and Unmet Data Needs for Specialty Drug Formulary Decisions in the United States.评估美国专科药物处方决策的满意度和未满足的数据需求。
J Manag Care Spec Pharm. 2016 Apr;22(4):368-75. doi: 10.18553/jmcp.2016.22.4.368.
10
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.继续医学教育/继续护理学教育文章：多发性硬化症的护理框架，第1部分：更新的疾病分类及特定情况下疾病修正治疗的应用
Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051.

引用本文的文献

1
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.理解美国药品使用中价值的支付方视角。
J Manag Care Spec Pharm. 2019 Dec;25(12):1319-1327. doi: 10.18553/jmcp.2019.25.12.1319.
2
The Potential Effect of the 21st Century Cures Act on Drug Development.《21 世纪治愈法案》对药物研发的潜在影响。
J Manag Care Spec Pharm. 2018 Jul;24(7):677-681. doi: 10.18553/jmcp.2018.24.7.677.

本文引用的文献

1
Optimization of Medication Use at Accountable Care Organizations.优化问责制医疗组织中的药物使用。
J Manag Care Spec Pharm. 2017 Oct;23(10):1054-1064. doi: 10.18553/jmcp.2017.23.10.1054.
2
Why Value Framework Assessments Arrive at Different Conclusions: A Multiple Myeloma Case Study.为什么价值框架评估会得出不同的结论：多发性骨髓瘤案例研究。
J Manag Care Spec Pharm. 2017 Jun;23(6-a Suppl):S28-S33. doi: 10.18553/jmcp.2017.23.6-a.s28.
3
AMCP Partnership Forum: Driving Value and Outcomes in Oncology.AMCP 合作论坛：推动肿瘤学的价值和成果。
J Manag Care Spec Pharm. 2017 May;23(5):591-597. doi: 10.18553/jmcp.2017.23.5.591.
4
Assessment of the Level of Satisfaction and Unmet Data Needs for Specialty Drug Formulary Decisions in the United States.评估美国专科药物处方决策的满意度和未满足的数据需求。
J Manag Care Spec Pharm. 2016 Apr;22(4):368-75. doi: 10.18553/jmcp.2016.22.4.368.
5
Physician Perception of Patient Medication Adherence in a Cohort of Medicare Advantage Plans in Texas.德克萨斯州医疗保险优势计划队列中医生对患者药物依从性的认知
J Manag Care Spec Pharm. 2016 Mar;22(3):305-12. doi: 10.18553/jmcp.2016.22.3.305.
6
Motivating the unmotivated: how can health behavior be changed in those unwilling to change?激励缺乏动力者：如何改变那些不愿改变的人的健康行为？
Front Psychol. 2015 Jun 16;6:835. doi: 10.3389/fpsyg.2015.00835. eCollection 2015.
7
Design, implementation, and first-year outcomes of a value-based drug formulary.基于价值的药品处方集的设计、实施和第一年结果。
J Manag Care Spec Pharm. 2015 Apr;21(4):269-75. doi: 10.18553/jmcp.2015.21.4.269.
8
Implementation of cancer clinical care pathways: a successful model of collaboration between payers and providers.实施癌症临床护理路径：支付方和服务提供方合作的成功模式。
J Oncol Pract. 2012 May;8(3 Suppl):e38s-43s. doi: 10.1200/JOP.2012.000564.
9
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer.分析美国与欧洲在癌症治疗方面的医疗保健支出较高是否“物有所值”。
Health Aff (Millwood). 2012 Apr;31(4):667-75. doi: 10.1377/hlthaff.2011.1298.
10
Drug company-sponsored patient assistance programs: a viable safety net?制药公司资助的患者援助项目：一个可行的安全保障？
Health Aff (Millwood). 2009 May-Jun;28(3):827-34. doi: 10.1377/hlthaff.28.3.827.

改变医疗保健付费方式：价值是新的塑料吗？

Changing the Way We Pay for Health Care: Is Value the New Plastic?

机构信息

1 University of Florida College of Pharmacy, Gainesville.

出版信息

J Manag Care Spec Pharm. 2017 Oct;23(10):998-1002. doi: 10.18553/jmcp.2017.23.10.998.

DOI:10.18553/jmcp.2017.23.10.998
PMID:28944727
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10397745/
Abstract

Navarro is a clinical professor in the College of Pharmacy at the University of Florida, Gainesville, and is an assistant editor with the Journal of Managed Care and Specialty Pharmacy. Navarro reports consulting fees from Analysis Group, Amgen, Novartis, and Allergan.

摘要

纳瓦罗是佛罗里达大学盖恩斯维尔药学院的临床教授，也是《管理式医疗和专科药房杂志》的助理编辑。纳瓦罗报告称他有来自 Analysis Group、安进、诺华和艾尔建的咨询费。